AGF U.S. Market Neutral Anti-Beta Fund
AGF U.S. Market Neutral Anti-Beta Fund
Your view on BTAL
Overview
What the company does, where it operates, and who runs it.
About AGF U.S. Market Neutral Anti-Beta Fund
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- Not available
- Headquarters
- DE, US
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- Not available
- Headquarters
- DE, US
The fund will invest primarily in long positions in low beta U.S. equities and short positions in high beta U.S. equities on a dollar neutral basis, within sectors.
It will construct a dollar neutral portfolio of long and short positions of U.S. equities by investing primarily in the constituent securities of the Dow Jones U.S. Thematic Market Neutral Low Beta Index in approximately the same weight as they appear in the index.
The universe for the index is comprised of the top 1,000 eligible securities by market capitalization, including REITs.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for AGF U.S. Market Neutral Anti-Beta Fund, and the rating behind it. BTAL last traded at $12.22, 19.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for AGF U.S. Market Neutral Anti-Beta Fund. Starting points for AGF U.S. Market Neutral Anti-Beta Fund: P/E 19.4, EPS $0.62, beta -0.93 — an Asset Management name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for AGF U.S. Market Neutral Anti-Beta Fund. AGF U.S. Market Neutral Anti-Beta Fund paid $0.36 per share over the last year — a 2.9% yield at the current $12.22 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for AGF U.S. Market Neutral Anti-Beta Fund. Trailing twelve-month EPS for AGF U.S. Market Neutral Anti-Beta Fund stands at $0.62. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for AGF U.S. Market Neutral Anti-Beta Fund. AGF U.S. Market Neutral Anti-Beta Fund has reported as a listed company since 2011. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
AGF U.S. Market Neutral Anti-Beta Fund valued side by side against its closest peers. AGF U.S. Market Neutral Anti-Beta Fund is measured against Asset Management peers within the Financial Services sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold AGF U.S. Market Neutral Anti-Beta Fund, and how their positions are changing. At a $281.5M market value, institutional positions materially move AGF U.S. Market Neutral Anti-Beta Fund's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by AGF U.S. Market Neutral Anti-Beta Fund executives and directors. Shares of AGF U.S. Market Neutral Anti-Beta Fund have traded between $13.66 and $22.10 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming AGF U.S. Market Neutral Anti-Beta Fund. AGF U.S. Market Neutral Anti-Beta Fund is a $281.5M Financial Services company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming AGF U.S. Market Neutral Anti-Beta Fund. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for AGF U.S. Market Neutral Anti-Beta Fund. Coverage tracks AGF U.S. Market Neutral Anti-Beta Fund within Asset Management (Financial Services). Press releases and market coverage, newest first.